Resistance to bacteriophage incurs a cost to virulence in drug-resistant Acinetobacter baumannii

is a critical priority pathogen for novel antimicrobials (World Health Organization) because of the rise in nosocomial infections and its ability to evolve resistance to last resort antibiotics.